Access cutting-edge hematologic malignancies treatment through this clinical trial at a research site in Hackensack. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Hackensack location
Access hematologic malignancies specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hematologic malignancies treatment provided free
Check if you qualify for this hematologic malignancies clinical trial in Hackensack, NJ
No-Cost Study Care
Local to Hackensack
Convenient for NJ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of this study is to evaluate the safety and efficacy of nemtabrutinib (formerly ARQ 531) in participants with hematologic malignancies of chronic lymphocytic leukemia (CLL)/ small lymphocytic lymphoma (SLL), Richter's transformation, marginal zone lymphoma (MZL), mantle cell lymphoma (MCL), follicular lymphoma (FL), and Waldenström's macroglobulinemia (WM).
Sponsor: Merck Sharp & Dohme LLC
Yes, this clinical trial (NCT04728893) has an active research site in Hackensack, NJ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hematologic malignancies treatment options in Hackensack, NJ, this clinical trial (NCT04728893) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hackensack research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hematologic malignancies specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all hematologic malignancies clinical trials near you to find additional studies recruiting in your area.
See all interstitial cystitis clinical trials recruiting in Hackensack — not just this study.
Browse Interstitial Cystitis Trials in Hackensack →